closer to $15 billion or $750 would be fair at this juncture and a drop in the bucket for GILD. Future potential NASH revenue is $15 billion +, they would be getting a very good price at that level.
PBYI float is 20 million shares, ICPT is 12 million. PBYI now up 267% in premarket. You will see ICPT with this upside very soon.
From January high in the $140's down to the high 50's today, then after hours in the $170's! On trial news. By the way, they have a float of 20 million shares, sound familiar? A 200% increased would put ICPT close to $700. This is a reality folks, this can and does happen. The greedy shorts in PBYI now know what it feels like.
ICPT is the only one you want to be in to follow this blockbuster drug. All so often, you will see a smaller company trying to ride the coat tails of the bigger, real story. The morons will come out of the woodwork and desperately try to pump their pos on unsuspecting suckers trying to make a quick buck, that is why they have infested this board. This is no different than bucket shop pumpers who try to inflate imaginary stocks so they can sell their shares to you at a high price and you are left holding the bag. This company may have a drug in trials, but it will not stand up to ICPT. There were plenty of erectile dysfunction drugs that went to trial, there are really only two that you know, and this is the case with the majority of blockbuster drugs and it will be the case with ICPT.
I am almost worried that a buyer will come in at this vulnerable level, this will go to $900, but may get taken out between $500 and $750, we will not be able to see the full value, but I will take it.
It will be just a matter of time now before we see that this is the real deal. The next thing we hear from the company could be the catalyst that moves this past $450.
Actually, you are very wrong in your assessment. Her salary is probably minimal, so her pay is dependent on options and the stock going up. Second, she left a job making seven figures regardless of what happens. Third, analysts that leave their positions and go to companies do not get easily hired back, specifically if "does not work out". One who leaves for a hedge fund may be able to reenter the circuit, but not a senior executive of a company, this is a one shot deal. Fourth, her employment with the company is a MAJOR factor in the companies potential and consider it a testament to its probability of success. Reputationally, professionally and financially, she has made this decision based on intense due diligence and full analysis of the risk/reward and confidence of probability of the positive outcome.
NASH patients have elevated lipid levels as part of their overall condition anyway. It was always expected that increased cholesterol should be manageable with statins or other standard anti-lipid therapy. I am not sure why people are trying to make this into something it is not.
First, if you are simply "on" Genfit, then why waste your time here? Second, based on how grammatically and punctually wrong your writing is, you may want to rethink trying to sway anyone here, most people will not listen to someone who resembles the intelligence of a fourth grader.
$650-$750 this is going to be monumental, the drug is a blockbuster and the results will prove it. The nonsense that is spewed by shorts about complications is ridiculous. The results will show the true power of this drug and those who risk being short will be very sorry they took this risk. PS you can cover your short with my shares at $749.
google Mark Schoenebaum ISI group weekly video
GILD already has simtuzumab, which has been very slow to enroll and they already expressed a limited conviction on an outcome. They would certainly benefit from ICPT's progress and the promise of their studies.
I think for sure she knew. She is a relatively conservative analyst (and Dr.) who put a $875 price target on the stock (when it was at this level) and realized the potential then. After doing her full due diligence, I am sure she is now even more confident and more sure of its promise and success. You don't just leave a high paying, high profile analyst position to take a chance with a drug company.
Yes, we all saw this on June 25th, by the way, this was not a press release, it was casually said at a conference. The company said in January when the stopped the trial that they would have to give the patients 24 weeks after taking the drug before accurate results will be compiled and released. That was about 24 weeks ago so some time is expected to gather and analyze the data before distribution, perfectly normal.
The fact is, that when the market is down and volume dries up, people can move this stock. People who put too much of their money into it get scared and cant handle the volatility. They are smart enough to know this threshold and then the bring it back up, a low float and low volume allow this to happen.
And there you have it! a glimpse into the type of moron that is going against this stock, "Yes there are news!" The rest is even better..."The end of july is the Flint results for OCA LDL troubles" The only troubles are the ones you have getting a job or succeeding in society. Before you get very hurt financially, go back to McDonalds and beg for a job. "I let you understand" CLASSIC!!!
This stock is currently down because people who trade it know how to move it. There has been no news that would justify this movement. Those who are currently responsible for this movement have been shorting down to this level, I assume they use an average price. they then have to buy it back at some point, which shows exaggerated moves to the upside, as long as they cover for more than it costs to buy it back, they make money. This is the problem with low float stocks that are high in price. The best part is, when good news comes, all this goes out the window, the short position is destroyed as well as this strategy. Rest assured, I will sit and hold through this nonsense and be rewarded handsomely when all is said and done. Until then, don't them scare you, and don't believe any bs they try to spread to scare you, they are trying to profit from your fear. This will be a blockbuster drug and millions of lives will be saved and billions of dollars will be made.